InvestorsHub Logo
Replies to #138290 on FLEX NATION

PennyStock Alert

07/03/17 12:36 PM

#138618 RE: Flex #138290

ARYC up 40% today on high volume!!!

Penny Machine

07/19/17 4:01 PM

#139049 RE: Flex #138290

Cya Tomorrow Flex!

Penny Machine

08/23/17 9:19 AM

#139993 RE: Flex #138290

Good morning Flex!

Penny Machine

08/24/17 9:10 AM

#140022 RE: Flex #138290

Good morning Flex!

Penny Machine

08/30/17 8:56 AM

#140166 RE: Flex #138290

Good morning Flex!

Penny Machine

10/12/17 9:02 AM

#141839 RE: Flex #138290

Good morning Flex!

Penny Machine

10/13/17 4:01 PM

#141922 RE: Flex #138290

Have a Great Weekend Flex! Hope to see you around next week!

Penny Machine

10/16/17 9:12 AM

#141931 RE: Flex #138290

Good morning Flex!

Crazy Money

11/13/17 5:23 AM

#142892 RE: Flex #138290

I'm a real American :-)

Penny Machine

12/12/17 8:46 AM

#143760 RE: Flex #138290

Good morning Flex!

Penny Machine

12/26/17 9:19 AM

#144133 RE: Flex #138290

Good Morning Flex!

Penny Machine

01/02/18 4:02 PM

#144258 RE: Flex #138290

Cya Tomorrow Flex!

goarmy123

01/07/18 9:00 PM

#144309 RE: Flex #138290

Hey! Where you and Wong been? Got a hot one for you girls! ;-) bring nitwit as well.

Btown

02/06/18 6:46 PM

#145157 RE: Flex #138290

ICLD A/H News receives 5million for the sale of ADEX

IR says dilution done and OS should be maxed out

https://finance.yahoo.com/news/intercloud-announces-definitive-agreement-sale-224506525.html

WALL STREET KID

03/26/18 11:27 AM

#146211 RE: Flex #138290

$WALL STREET KID'S Ultimate $RSII $RBIO Due Diligence Masterpiece Covering Jan 2017 To Present Be sure to check it's chart











CLICK HERE TO FOLLOW THE WALL STREET KID
















































$RSII Has The Same BOD & Core Shareholders/Ownership As $PAOG And They Are In It To Win It





$CHECK FINRA DAILY: $RSII Filed For Name, Ticker, Cusip Number Changes In May 2017, And Is Using Same Counsel They Used When Converting to $PAOG













































$I Plan On Having $RSII As A Long Term Holding But Of Coarse Will Pull My Original Money Out At Much Higher Levels And Ride The FREEBIE Waves. I'm A Open Book.


https://investorshub.advfn.com/uimage/uploads/2017/8/2/xjddvCapture.JPG]">https://investorshub.advfn.com/uimage/uploads/2017/8/2/xjddvCapture.JPG]" />










$RSII & PAOG SECURITIES COUNSEL










$RSII IS MEDICAL MARIJUANA COMPOUNDING BIOSCIENCE PHARMACEUTICAL and there is nothing that the AG can do




CLICK HERE TO FOLLOW THE WALL STREET KID





































$The New $RSII Has Awesome Follow Through, Commitment, And Communication In My Opinion No Complaints Coming From The Wall Street Kid These Days Since Change Of $RSII Ownership & BOD















































$It's Only A Matter Of Time Before The USA Legalizes In My Opinion

























$Do You Have





$I Do!!!

And Day To Day Movements Have No Impact On Me. Check Image below to see how big my $RSII Risk Tolerance is then check my post around the time. I know what I own






$MORE $RSII PRODUCTS BEYOND CANNOPHEN THE WEED PILL THAT ARE IN THE PIPELINE BELOW INCLUDING TSW PAIN CREAM



















CLICK HERE TO FOLLOW THE WALL STREET KID









Murdoc

07/20/18 2:57 PM

#147777 RE: Flex #138290

$SAGD Twitter @sativagrowth confirms 200m OS reduction and says acquisition news in next few days

~ Blue ~

11/06/18 2:01 PM

#148608 RE: Flex #138290

$CCTL(.0006) 166 million volume 20% up. George Sharp's stock

StockDetective

02/02/19 10:49 AM

#149546 RE: Flex #138290

Arrayit Corp (ARYC) has done what no one else has been able to do!

Now apart from Sutter Health, Kaiser Permanente, and Walgreens, I also believe the company had an earlier deal with Kroger if you look back at the press releases and connect a few dots.



Impressive work from the good doctor.

Dr Mark Schena also known as the “Father of Microarray Technology," has created a medical breakthrough... First of its kind allergy testing with a simple prick of the finger tip, which is now being used by clinicians for accurate allergy testing.



This medical breakthrough opens the gates for the company’s pipeline tests. OvaDx & Parkinson’s Disease PDx.



Lets travel down memory lane on my company shareholder’s tour in Silicon Valley right next to the new Apple building.

I spoke with Rene & Mark Schena face-to-face and also went hands on with their technology like many others have taken the time to do. I highly recommend it to anyone who has not done so already. I was impressed and this really boosted my confidence as a shareholder.

During the tour I was given the option for a free food intolerance test or an allergy test. I went with the allergy test. As I added my four drops of blood on the blood card, I observed hundreds of Pinnertests on the lab table waiting to be processed. If I had to guess, I would say roughly between 200-300 tests. I was told it was one days shipment... Now that’s Pinnertest alone and before all the big endorsements even came about.

Most of the equipment being used to process these test is reusable. Mass production would not be a problem for this company as robust machinery do most of the work.

I also asked about the OvaDx product and was advised that the details of the test were confidential at the time. As I pressed the issue a bit further was told that there was going to be a press release in the future regarding the matter. The subject was then changed as the good doctor advised me that he had said too much already.

When i finally viewed my allergy test report, which is almost identical to the Allergenex report besides it stating Arrayit on top (see sample report)...

https://allergyfreesolutions.com/item/sample-reports/

The name Dr Julie A. Taguchi showed up as the lab director of Arrayit. The report also comes with Arrayit’s CLIA laboratory number. But wait... Dr Julie A. Taguchi is also described on the OvaDx product details down below and also has ties to Kaiser Permanente.



From the website:

Can ovarian cancer be cured by early stage detection and treatment?

Yes. According to Dr. Julie A. Taguchi, MD, of the Sansum Medical Clinic in Santa Barbara, CA, surgical removal of stage IA ovarian tumors effectively cures ovarian cancer in a large percentage of patients without the requirement for chemotherapy. According to the medical literature, the 20-year survival rate for stage IA patients is very good.

http://www.arrayit.com/Microarray_Diagnostics/Ovarian_Cancer_Forum/ovarian_cancer_forum.html

Doctors and nurses currently use 15 million CA-125 tests per year to monitor ovarian cancer, generating approximately $2 billion in worldwide revenue. Capturing 1% of the ovarian cancer monitoring market would generate $97.5 million in annual revenues for Arrayit through the manufacture and sale of 150,000 OvaDx® tests at $650 per test. Our Sunnyvale laboratories have more than adequate capacity to process 150,000 OvaDx® tests per year upon FDA approval.

This website was updated last year.

In Development

Arrayit Corporation and Avant Diagnostics, Inc. provide the market’s first large panel biomarker monitoring test for ovarian cancer (OVC). OvaDx® is advanced microarray-based test that measures the activation of the immune system in blood samples in response to early stage ovarian tumor cell development. Research studies with OvaDx® indicate high sensitivity and specificity for all types and stages of ovarian cancer including stage IA-IV borderline serous, clear cell, endometrioid, mixed epithelial, mucinous, serous, and ovarian adenocarcinoma. Upon FDA approval, Avant will offer OvaDx® as an elective test for women seeking greater wellness and for women in the elevated risk category for ovarian cancer. OvaDx® will be used by doctors to advance the forefront of ovarian cancer treatment including improved surgical options, more effective chemotherapies, and to supplement existing tests including CA-125, OVA1®, and transvaginal ultrasound.

http://arrayit.com/Microarray_Diagnostics/OvaDx_Ovarian_Cancer_Test/ovadx_ovarian_cancer_test.html



More catalysts under way with Parkinson’s Disease PDx™ test:

The Parkinson’s Institute video link:



Arrayit has leveraged the company’s patented and proprietary microarray discovery platform to decipher the molecular basis of Parkinson’s Disease (PD). This important research project offers exciting promise for the pre-symptomatic and post-symptomatic diagnosis and treatment of this serious neurodegenerative condition. Arrayit is currently seeking a strategic partner to accelerate FDA approval of the Arrayit PDx™ Parkinson’s Diagnostic Test, speed the benchmarking of PDx™ as a companion diagnostic, and determine and enhance the efficacy of pipeline therapeutic proteins and small molecules.

Arrayit PDx™ Pre-Symptomatic Test for Parkinson’s Disease will be submitted to the United Sates Food and Drug Administration (FDA) as a 510(k) submission in the near future.

http://www.arrayit.com/Microarray_Diagnostics/Parkinsons_Disease/parkinsons_disease.html

Arrayit Corporation and The Parkinson's Institute Research Collaboration

“This collaboration provides an important first step towards unraveling the mysteries of Parkinson's disease," stated Dr. Mark Schena, Ph.D., Arrayit President. "We look forward to working with The Parkinson's Institute to decipher the molecular basis of the disease," he continued. The Parkinson's Institute Assistant Professor Dr. Birgitt Schuele, M.D. added, "Parkinson's disease represents a serious and challenging medical condition. We are pleased to be deploying Arrayit technology to combat this illness.”

About The Institute

WHO WE ARE
The mission of The Parkinson’s Institute (The PI) is to provide comprehensive patient care, while discovering new treatment options to improve the quality of life for all Parkinson’s disease (PD) patients. As America’s only independent non-profit organization combining research and patient care for PD under one roof, we are committed to changing the landscape of movement disorder treatment and research. Since its founding, The PI has helped thousands of PD patients better manage their disease, developed new treatments for PD, and published groundbreaking research aimed to close the gap between science and practical care. By focusing on all three avenues of PD - cause, care and cure - The PI is a powerful force in PD research.

http://www.thepi.org/about-the-institute/

Arrayit Scientific Solutions Inc...Marketing a test for Parkinson’s Disease.

https://www.nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=dsbOEiMfG9LB4qKRsPW%252bzw%253d%253d&nt7=0



Wait there’s more folks... Just read the letter to shareholders.

http://www.arrayit.com/confidential/Letter-to-Arrayit-Shareholders.pdf

During 2018, the company achieved major milestones, including 25 years in business. Arrayit established a nationwide network of 1,700 allergy sales professionals, signed allergy testing contracts with more than 300 medical clinics, launched the Patient Data Solutions allergy portal for doctors and clinics, and fulfilled a clinical instrumentation contract with the FDA after a face-to-face regulatory meeting, among others.

At year end, we implemented a new electronic medical billing solution and we expect to bill $1 million per week for our health and wellness tests.

We will make new hires and refine our future business and financial objectives, including potential up listing.



New hires before going to NASDAQ...

We have also come to learn that Spiriplex is one of Arrayit’s allergy marketing partners. They seem to have great members on the board that I would love to see come over in due time. One of those members is affiliated to Sutter Health.

https://spiriplex.com/about-us/

The company is further waiting on FDA approval and an NIH clinical trials update is due this month (February).

“Diagnostic Test: Spiriplex Allergenex Microassay”

https://clinicaltrials.gov/ct2/show/NCT03514303

Sponsor is United Allergy Services



I strongly believe this stock will be trading in the dollars range this year. So don’t miss this opportunity because finds like this are extremely rare.

~ Blue ~

03/15/19 10:30 PM

#150073 RE: Flex #138290

GMER ~Undervalued Gaming Stock, Tiny Float~ New DD

1) GMER is a OTCQB stock.

Good Gaming Inc. is a leading competitive gaming and social network platform targeting over 250 million esports players and participants worldwide who want to communicate with each other, develop strategies, and compete at novice, competitive and professional levels. Good Gaming Inc. has taken a strategic multifaceted approach in the esports industry with products and services ranging from multiple Minecraft servers, a proprietary tournament platform, high school esports leagues and soon-to-come virtual reality centers. The esports industry continues to experience exponential growth going from $500 million to $1.2 billion over the last two years while industry analysts forecast a $5 billion global industry by 2020. Good Gaming Inc. seeks to create and exploit opportunities as the industry allows.

www.good-gaming.com
(888) 295-7279
corporate@good-gamimg.com
https://www.otcmarkets.com/stock/GMER/profile
----------------------------------------------------------------------

2) GMER share structure:

A/S: 200 million
O/S: 53.9 million
Float: 38 million

https://www.otcmarkets.com/stock/GMER/security
--------------------------------------------------------------------

3) CMGO is a major shareholder. It holds 100% of C pref. shares, 61.72% of B pref. shares OF GMER

https://www.otcmarkets.com/filing/html?id=11990586&guid=w1OZUaqrKGEc93h

Under name of CMGO CEO Glenn Laken's wife Barbara Laken.
--------------------------------------------------------------------

4) GMER Retires $46,531 of Convertible Debt Through a Corporate Share Buyback

https://www.otcmarkets.com/stock/GMER/news/Good-Gaming-Inc-Retires-46531-of-Convertible-Debt-Through-a-Corporate-Share-Buyback?id=212924
--------------------------------------------------------------------

5) The Company is working to:

Aggressively search for gaming influencers for the competitive gaming division
Expand player counts for competitive esport play
Establish an internet streaming channel as a premier place for content and viewership
Competitive play and exposure
Increase regional live tournaments to include iconic geographical locations throughout the U.S.
Expand Minecraft exposure
Continue to seek additional opportunities within the esport gaming industry
Look for strategic acquisitions with operating assets that will help the Company show exponential growth

https://www.otcmarkets.com/stock/GMER/news/Good-Gaming-Inc-Provides-Shareholder-Updates-for-the-Month-of-November-2018?id=213618
--------------------------------------------------------------------

6) Plan of Operation – Milestones: EXPECTING PROFITABILITY THIS YEAR

We are at the early stage of our new business operations. Over the next twelve months, our primary target milestones include:


1. Continue to achieve substantial growth within our Minecraft division. We expect this to be a profitable center for us.

2. Launch an in-person gaming product. We expect to launch this product in the fourth quarter of 2018 and anticipate substantial growth by the end of the year.

3. Continue to evaluate opportunities which have synergies to our existing business line.

4. Anticipate sustainable financial profitability this year.

PAGE 3

https://www.otcmarkets.com/filing/html?id=13068732&guid=e8ptUHXtV1I6s3h
--------------------------------------------------------------------

7) GMER Signs Agreement With Popular YouTube Esports Team Forknife to Increase Minecraft Exposure

https://www.otcmarkets.com/stock/GMER/news/Good-Gaming-Inc-Signs-Agreement-With-Popular-YouTube-Esports-Team-Forknife-to-Increase-Minecraft-Exposure?id=216681

............................******.................................


This is my DD. You should do your own dd before investing any stock.


~Blue~

Ksweets101

04/02/19 10:40 PM

#150271 RE: Flex #138290

SSOF 27 million dollar deal stickied to top of SSOF board- check it out

~ Blue ~

05/18/19 2:56 PM

#150735 RE: Flex #138290

$CMGO ~Posted $561K Net Profit, Debt Free, Low Float~DD

1) CMGO will receive 2.75 Million Dollars from The Settlement in the next 2.5 years. Each Month about 90,000 dollars cash.

https://backend.otcmarkets.com/otcapi/company...39/content

2) CMGO posted Net Profit for 1ST QTR $561,000

https://ih.advfn.com/stock-market/USOTC/cmg-holdings-group-inc-pn-CMGO/stock-news/79936570/cmg-holdings-reports-strong-first-quarter-results

CMGO's sub company XA made net profit in 2018.

https://backend.otcmarkets.com/otcapi/company...27/content
--------------------------------------------------------------------

3) CMGO has $317,000 Cash on Hand by end of the first quarter of 2019.

https://ih.advfn.com/stock-market/USOTC/cmg-holdings-group-inc-pn-CMGO/stock-news/79936570/cmg-holdings-reports-strong-first-quarter-results

4) 3 New Clients > $1 MILLION EACH

https://ih.advfn.com/stock-market/USOTC/cmg-holdings-group-inc-pn-CMGO/stock-news/79936570/cmg-holdings-reports-strong-first-quarter-results

XA's one recent event was 1.1 Million Dollars.

XA will be producing this year’s Coachella after-party for Moschino this weekend, with an estimated gross in excess of 1.1 million dollars. We expect this event to kick off a banner year for XA.

https://backend.otcmarkets.com/otcapi/company/dns/news/document/35739/content
-----------------------------------------------------------------

5) CMG0 eliminated all XA DEBT

https://ih.advfn.com/stock-market/USOTC/cmg-holdings-group-inc-pn-CMGO/stock-news/79936570/cmg-holdings-reports-strong-first-quarter-results

6) 450 MILLION A/S AND O/S.. SHARES MAXED OUT.

https://www.otcmarkets.com/stock/CMGO/security


7) CEO GLENN B. LAKEN Paid multi-cents share price for each share he holds

CEO & DIRECTOR BUYS - CODE P with Institutional....

https://www.otcmarkets.com/filing/html?id=10340528&guid=Hq4yUWaAZZYV7th#PRIMARY_DOC_HTM_F1

https://www.otcmarkets.com/filing/html?id=10107939&guid=Hq4yUWaAZZYV7th

DIRECTOR Kovacs David J


https://www.otcmarkets.com/filing/html?id=10061951&guid=Hq4yUWaAZZYV7th

Typenex Co-Investment, LLC still holding 44,588,286 Million Shares.

https://www.otcmarkets.com/filing/html?id=11322192&guid=Hq4yUWaAZZYV7th

MOUHANED KHOURY still holding 27,990,616 Million Shares.

https://www.otcmarkets.com/filing/html?id=13035123&guid=Hq4yUWaAZZYV7th
--------------------------------------------------------------------

8) Shareholder friendly experienced CEO

https://www.cmgholdingsinc.com/about

9) 16 Million Dollars NOL, tax advantage.

https://backend.otcmarkets.com/otcapi/company...27/content


10) NEW WEBSITE NOW UP https://www.cmgholdingsinc.com/

11) Most Recent News link: https://bit.ly/2VIXIuN


Your witnessing a real turnaround story here like Fergus said.

For me, It is Hard to find a solid stock like CMGO on the otc market. My target multi-bagger ..

This is my DD.. Please read, check links and make your own DD BEFORE INVESTING OR SHORTING ANY STOCK.

Blue.


~ Blue ~

05/28/19 11:03 AM

#150807 RE: Flex #138290

CMGO 29.1% up volume increases

~ Blue ~

08/12/19 5:42 PM

#151510 RE: Flex #138290

$PVDG(.0014) ~52WK Range 0.001 - 0.33 Float 126M, O/S 175M, otcqb fully reporting

https://www.otcmarkets.com/stock/PVDG/quote

abazaba375

03/03/21 10:05 PM

#155439 RE: Flex #138290

CNGT bang